Michael Singer advises clients on a wide variety of antitrust matters related to mergers and acquisitions, including representing clients before the Department of Justice and Federal Trade Commission. Mr. Singer has worked with clients across a diverse range of industries, including aerospace and defense, consumer products, technology, health care, pharmaceuticals, financial services and private equity. His representations include:

  • E.I. du Pont de Nemours and Company in its $130 billion merger of equals with The Dow Chemical Company;
  • Express Scripts Holding Company in its $67 billion acquisition by Cigna;
  • Rockwell Collins, Inc. in its $30 billion acquisition by United Technologies Corporation;
  • EMC Corporation in its $67 billion acquisition by Denali Holdings, Inc., the parent company of Dell, Inc.;
  • Citrix Systems, Inc. in the $1.8 billion acquisition of its GoTo business by LogMeIn, Inc.;
  • Springleaf Holdings, Inc. in its $4.25 billion acquisition of OneMain Financial;
  • Ash Grove Cement Company in its $3.5 billion acquisition by CRH plc;
  • Boral Ltd. in its $1.8 billion acquisition of Headwaters, Inc.;
  • Hospira, Inc. in its $16 billion acquisition by Pfizer, Inc.; and
  • numerous sales and acquisitions for Veritas Capital and its portfolio companies.

Mr. Singer also provides general antitrust counseling and has advised clients on a variety of matters, including joint ventures, strategic alliances, unilateral conduct, and pricing and distribution issues.

Additionally, Mr. Singer routinely represents veterans on a pro bono basis in applications and appeals for compensation and benefits before the Department of Veterans Affairs.



  • J.D., Fordham University School of Law, 2014
  • B.A., Hamilton College, 2009


  • New York

Michael B. Singer

Associate, Antitrust/Competition